BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 12666269)

  • 1. [When drug withdrawal for safety concerns may be harmful. A case report with tetrabamate].
    Raveloarimisy L; Gras-Champel V; Lemaire-Nanni E; Burde-Hamm F; Andréjak M; Guilbaud JC
    Therapie; 2002; 57(6):593-5. PubMed ID: 12666269
    [No Abstract]   [Full Text] [Related]  

  • 2. [Acute liver failure following tetrabamate].
    Binder D; Jost R; Flury R; Salomon F
    Schweiz Med Wochenschr; 1995 May; 125(19):965-9. PubMed ID: 7761807
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A controlled double-blind study of tetrabamate versus lorazepam and placebo in generalized anxiety].
    Lôo H; Malka R; Hantouche E; Lancrenon S; Guelfi JD
    Encephale; 1991; 17(4):295-300. PubMed ID: 1959498
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Stevens-Johnson syndrome induced by tetrabamate in a patient with HIV infection].
    Lleonart R; Nomdedeu J; Sambeat MA
    Med Clin (Barc); 1992 Oct; 99(12):474. PubMed ID: 1460902
    [No Abstract]   [Full Text] [Related]  

  • 5. Double blind study on the efficacy and safety of tetrabamate and chlordiazepoxide in the treatment of the acute alcohol withdrawal syndrome.
    Radouco-Thomas S; Garcin F; Guay D; Marquis PA; Chabot F; Huot J; Chawla S; Forest JC; Martin S; Stewart G
    Prog Neuropsychopharmacol Biol Psychiatry; 1989; 13(1-2):55-75. PubMed ID: 2664886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Double-blind study of the efficacy of tetrabamate and tiapride in the treatment of alcohol deprivation syndrome].
    Santo Domingo Carrasco J; Bravo Ortiz MF; Barroso Cañizares A; Caballero Martín L
    Med Clin (Barc); 1985 Oct; 85(13):533-6. PubMed ID: 3908847
    [No Abstract]   [Full Text] [Related]  

  • 7. Liver injury due to tetrabamate (Atrium): an analysis of 11 cases.
    Dumortier J; Bellemin B; Jacob P; Berger F; Chevallier M; Scoazec JY; Vial T
    Eur J Gastroenterol Hepatol; 2000 Sep; 12(9):1007-12. PubMed ID: 11007137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Anxiolytic efficacy and tolerance of tetrabamate in anxious patients abusing alcohol. Multicenter double-blind versus placebo study].
    Lôo H; Guelfi JD; Malka R; Brion S; Cottin M; Gailledreau J; Raab A; Salfati M; Sarda A; Godchau M
    Encephale; 1986; 12(5):291-7. PubMed ID: 3545785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Atrium 300 hepatitis. A new case].
    Cayla JM; Fandi L; Arnould P; Degott C; Gouffier E
    Presse Med; 1995 Nov; 24(35):1665. PubMed ID: 8545391
    [No Abstract]   [Full Text] [Related]  

  • 10. [Severe acute hepatitis caused by Atrium].
    Brocheriou I; Zafrani ES; Mavier P
    Gastroenterol Clin Biol; 1993; 17(4):305-6. PubMed ID: 8339895
    [No Abstract]   [Full Text] [Related]  

  • 11. [Atrium-induced hepatitis with autoimmune pattern].
    Pariente EA; Mineur D
    Gastroenterol Clin Biol; 1992; 16(5):485-6. PubMed ID: 1526409
    [No Abstract]   [Full Text] [Related]  

  • 12. [Atrium-related hepatitis. Report of four cases].
    Horsmans Y; Larrey D; Pessayre D; Rueff B; Degott C; Benhamou JP
    Gastroenterol Clin Biol; 1991; 15(8-9):648-52. PubMed ID: 1684328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Tetrabamate-induced hepatotoxicity. Report of seven cases and literature review].
    López-Torres E; Lucena MI; Andrade RJ; García Ruiz E; Fernández MC; Peláez G; Soria de la Cruz MJ; Pizarro A
    Gastroenterol Hepatol; 2002 Dec; 25(10):589-93. PubMed ID: 12459120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Acute hepatitis associated with microvesicular steatosis induced by Atrium].
    Schneider S; Charles F; Chichmanian RM; Montoya ML; Rampal P
    Gastroenterol Clin Biol; 1995 Dec; 19(12):1064-5. PubMed ID: 8729422
    [No Abstract]   [Full Text] [Related]  

  • 15. [Tetrabamate in the treatment of agoraphobia].
    Iruela Cuadrado LM; García Páez JM
    Med Clin (Barc); 1988 Nov; 91(18):717. PubMed ID: 3230993
    [No Abstract]   [Full Text] [Related]  

  • 16. Oral phenobarbital loading: a safe method of barbiturate and nonbarbiturate hypnosedative withdrawal.
    Janecek E; Kapur BM; Devenyi P
    CMAJ; 1987 Sep; 137(5):410-2. PubMed ID: 3621099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psychotropic discontinuation symptoms: a case of withdrawal neuroleptic malignant syndrome.
    Stonecipher A; Galang R; Black J
    Gen Hosp Psychiatry; 2006; 28(6):541-3. PubMed ID: 17088172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Influence of psychotropic drugs on thrombocytes aggregation in patients with epilepsy].
    Morozov GV; Semenova NV; Slastenko OA; Mishchenko AL
    Zh Nevrol Psikhiatr Im S S Korsakova; 2004; 104(11):60-1. PubMed ID: 15581040
    [No Abstract]   [Full Text] [Related]  

  • 19. The use of phenobarbital in treating abstinence in newborns exposed in utero to psychoactive agents.
    Finnegan LP; Michael H; Leifer B
    NIDA Res Monogr; 1984 Mar; 49():329. PubMed ID: 6434979
    [No Abstract]   [Full Text] [Related]  

  • 20. [Use of Atrium 300 in the withdrawal of alcoholic patients].
    Fontan M; Taine D
    Therapeutique; 1973; 49(7):463-6. PubMed ID: 4595358
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.